immune bodies developing in the blood, to which the protective power is due. G. and F. Klemperer considered the protective power dependent upon an antitoxic action of the serum. R6mer 5 holds the opinion that the chief action is bactericidal; while recently much stress has been laid on the development of opsonins or bacteriotropins in the serum. In the absence of the demonstration of a pneumococcus toxin, the view that the protective power may be due to an antitoxin is purely hypothetical. Even RSmer has not been able to demonstrate the bactericidal power in vitro of post-pneumonia serum. Virulent pneumococci are so resistant to the action of opsonins, as detected by the ordinary technique, that even artificial immune sera, having far greater protective power than any post-critical sera so far studied, show very slight if any increase in opsonic power for such virulent organisms. By the use of a different technique, Neufeld and Haendel have demonstrated that such post-critical sera may show an increase of *heir property of favoring phagocytosis, both in vivo and in vitro. This property, they consider, depends on the presence of bacteriotropins.
In the effort to find an explanation of the crisis, however, it is of great importance to determine definitely whether protective substances appear constantly in the post-critical serum, and whether the time of their appearance bears any relationship to the time of crisis or recovery. The mere demonstration of the occasional presence of protective substances in post-critical sera is not sufficient to permit drawing any conclusions as to their relationship to the phenomenon.
The blood obtained from a series of patients has therefore been studied to determine whether such substances are presen~t, and if so, to determine the time of their appearance. No effort has been made to determine the kind of immune bodies present.
EXPERIMENTAL PART.
Methods.--The sera for the experiments presented in this paper were obtained by venous puncture of patients with typical lobar pneumonia. The blood was allowed to clot, the serum separated, and kept in the dark on ice until used. The organism employed in each experiment was obtained, when possible, either from the blood or sputum of the patient whose serum was to be tested. The organism in each instance was isolated before ~he occurrence of the crisis. It has been found of some service, in procuring pure cultures from sputum, to inject at the same time a small quantity of human serum which seems to inhibit the growth of contaminating bacteria. In case the pneumococcus, when isolated, was of low pathogenicity, the virulence was raised by successive animal passages until a dose of o.oooooi of a cubic centimeter of a broth culture was sufficient to kill. White mice of as nearly the same age and size as possible were used as experimental animals. Twenty-four hour broth cultures fresh from animals were used for infection, and the serum and culture to be tested were mixed in varying quantities in the barrel of a syringe and immediately injected intraperitoneally. The animals were watched for from five to ten days, according to the rate at which the culture killed, and those surviving this time were considered protected. A small number of sera were tested for protective power against a typical laboratory strain of pneumococcus; in all other instances, the sera were tested against homologous strains isolated from the patients.
PROTECTIVE POWER
OF HUMAN SERA AGAINST A TYPICAL PNEUMOCOCCUS.
Experiment 1.--Serum t23 was obtained from a patient with typical pneumonia of the right lower lobe. The temperature fell by lysis on the seventh day of the disease. The temperature again rose the next day and remained slightly elevated for about six days. The blood culture was negative. The organism used for infection was pneumococcus Neufeld I, a strain of constant high virulence for animals.
Experiment e.--The serum (4o5) for this test was obtained from a patient with partial pneumonic consolidation of the left lower lobe. The temperature fell by lysis from the eighth to the ninth day of the disease and remained normal. The blood culture was negative. The protective power of the serum was tested against pneumococcus Neufeld I. Experiment 4.--The serum (119) for this experiment was obtained from a patient with typical lobar pneumonia, terminating by lysis on the tenth day, although the temperature remained slightly elevated for six days thereafter. The pneumococcus used for infection was obtained from the patient's blood on the seventh day of the disease. When first isolated, o.5 c.c. of a twenty-four hour broth culture failed to kill a mouse. The virulence was raised by successive animal passages until o.oooooi c.e. was fatal for mice in forty-eight hours.
Quan-
Experiment 5.--The serum (132) was obtained from a patient with lobar pneumonia, terminating by lysis on from the third to the sixth day of the disease. The pneumococcus against which the specimens of sera were tested was isolated from the sputum, and the virulence raised by animal passage until o.oooi c.c. was fatal for mice in forty-eight hours. The blood culture was negative.
Quantity of culture in c.c. Experiment 6.--The patient from whom the serum (145) used in this experiment was obtained had typical lobar pneumonia. The temperature fell by lysis on the ninth day of the disease, rose again the next day, and remained slightly elevated until the fifteenth day, when it again returned to normal. The patient died thirty days later from a post-pneumonic nephritis. The organism was obtained from the sputum and was the so called Pneumoeoecus mucosus.
It was of extremely high virulence for mice. The blood culture was negative.
• ¢~ Experiment 8.--The serum (503) for this experiment was obtained from a typical case of lobar pneumonia, terminating by crisis on the eighth day of the disease. The blood cultures during the course of the disease were negative. The protective power of the serum was tested against two strains of pneumococci; one, pneumococcus X, a stock culture, had received a great number of animal passages; the other, pneumococcus IX, had been isolated from the sputum of the patient and passed through five animals until o.00ooo1 c.c. of a twenty-four hour broth culture was fatal for mice in forty-eight hours. It was possible to protect mice against infection with both strains by the use of the serum of a horse immunized to a single strain of pneumococcus Neufeld I.
Protection of Mice against Pneumococcus X (Stock Organism).
Quantity of Quanculture in tity of Survived. Survived. Survived.
Experiment 9 , --T h e f o l l o w i n g s p e c i m e n s of s e r a (5Ol) w e r e o b t a i n e d f r o m a p a t i e n t w i t h t y p i c a l p n e u m o n i a of t h e r i g h t u p p e r lobe. T h e r e w a s a p s e
u d oc r i s i s o n t h e fifth d a y of t h e disease, a n d a t r u e crisis o n t h e f o l l o w i n g day, a f t e r w h i c h t h e t e m p e r a t u r e r e m a i n e d n o r m a l . T h e ' p n e u m o c o c c u s u s e d in the, t e s t s w a s i s o l a t e d f r o m t h e p a t i e n t ' s s p u t u m a n d t h e v i r u l e n c e r a i s e d by a n i m a l p a s s a g e u n t i l o.oooooi c.c. o f a t w e n t y -f o u r h o u r b r o t h c u l t u r e w a s f a t a l in t h i r t y -s i x h o u r s . T h e b l o o d c u l t u r e w a s n e g a t i v e t h r o u g h o u t t h e disease.
Quantity of cukure in c.C. Experiment zL--The serum (554) used in this experiment came from a patient with typical pneumonia of the left lower lobe. The temperature fall was by crisis on the sixth day of the disease. The blood culture was negative. The pneumococcus was isolated from the sputum and the virulence raised until o.oooooi c.c. was fatal for mice in thirty-six hours. Experiment /./.--The serum (6o6) for this experiment was obtained from a patient with a severe attack of lobar pneumonia. The temperature fell by lysis on the eleventh day of the disease, but remained slightly elevated until the seventeenth day. The physical signs in the lungs cleared up slowly. The blood culture showed pneumococcus on the seventh day, and the organisms disappeared from the blood on the tenth day. The pneumococcus, when isolated, killed mice in the higher dilutions in from three to four days.
Experiment / o . --T h e s e r u m (5o2) f o r t h i s t e s t w a s o b t a i n e d f r o m a p a t i e n t s u f f e r i n g f r o m a s e v e r e a t t a c k o f l o b a r p n e u m o n i a . T h e t e m p e r a t u r e fell by lysis o n t h e e i g h t h d a y o f t h e disease, r e a c h i n g n o r m a l o n t h e t e n t h day. T h e b l o o d c u l t u r e s w e r e n e g a t i v e . T h e p n e u m o c o c c u s u s e d f o r i n f e c t i o n o f a n i m a l s w a s o b t a i n e d f r o m t h e p a t i e n t ' s s p u t u m , a n d a f t e r s e v e r a l a n i m a l p a s s a g e s o.oooooi c.c. o f a t w e n t y -f o u r h o u r b r o t h c u l t u r e w a s f a t a l f o r m i c e in t h i r t ys i x h o u r s .

Quantity
Experiment z4.--The serum (553) for the following test was obtained from a patient with a moderately severe pneumonia of the left lower lobe. There was a pseudocrisis on the fourth day of the disease. The true crisis occurred on the eighth day of the disease. The blood cultures were negative. The virulence of the pneumoeoecus isolated from the patient's sputum could not be raised successfully, so the same organism was used for infection of animals as in experiment 13.
Quantity of culture in c.c. Specimens of sera obtained at various stages of the disease in fourteen patients have been studied. The specimens of sera from ten of these patients were tested against homologous organisms. The sera from three of the cases were tested against a stock organism, Neufeld I, and from one case against an organism isolated from the blood of patient 6o6. The appearance of protective substances is more evident when sera are tested against homologous organisms. In the ten groups of sera tested against homologous organisms, all but one exhibited at some time the power to protect mice against infection. Of the four groups of sera tested against the stock organisms, three showed at no time any protective power. In experiment 14, the serum obtained on the day of crisis protected against IOO lethal doses of an organism obtained from the blood of patient 6o5. It has been shown by Neufeld and HaendeV that the immune bodies for various races of typical pneumococci are highly specific, and we have also found this to be the case in our study of the protective power of an immune serum produced from a type strain. It is, therefore, evident that in the present study the results can only be of importance in the cases where homologous organisms were employed. This is shown by experiment 8, in which the same specimens of sera were tested against two strains of pneumococci, one a stock culture and the other an organism isolated from the patient's sputum. At no time did the serum protect against the stock strain, whereas the post-critical sera protected regularly against one thousand times the lethal dose of the homologous organism.
The amount of protection afforded by the pneumonic sera examined has varied in different individuals. In comparison with the potency of sera obtainable by active immunization of larger animals, it has been small. The greatest amount of protection against strains of maximum virulence is seen in experiments 4 and 8. In both these instances it was possible to protect mice with specimens of serum obtained after the crisis against o.ooi of a cubic centimeter of a broth culture of a highly virulent pneumococcus, of which o.oooooi of a cubic centimeter of the same culture was fatal for mice in forty-eight hours, thus affording protection against one thousand times the lethal dose, a value that corresponds favorably with that of some of the commercial immune sera. In other experiments the protective power of the sera tested varied from ten to one hundred times the lethal dose.
The time at which the appearance of immune bodies in the blood was demonstrable varied somewhat. In only four cases was there any protective power demonstrable in the serum obtained before the crisis. In experiment I protective substances were present twelve hours before the drop in temperature. Inasmuch as no earlier specimen of serum had been obtained in this instance, it is impossible to say how long these bodies had been present. In experiment 5 serum obtained two days before the temperature fell showed slight protective power, but no greater than control serum from a patient with chronic endocarditis. In two other experiments, 8 and 14, single animals that had received ante-critical sera survived. In seven cases pro,tective substances either appeared for the first time or showed a marked increase in amount at the time of crisis or, in case of lysis, during the period when the symptoms were abating. In some of these instances no specimens of serum were obtained immediately before the crises, so that the immune bodies may have been present twenty-four hours or longer before the disappearance of symptoms. However, in experiment 4 the specimen of serum obtained twenty hours before the beginning of the critical drop in temperature contained no protective bodies. In two cases the serum taken during the period of defervescence exhibited little or no power of protection, even against homologous strains of pneumococcus, and it was not for some time later, in one case sixteen days, that the presence of protective substances in the blood was demonstrated. The sera of seven patients showed undiminished protective power as long as the individuals were under observation,--from five to twenty days. In five cases there was a drop in the protective power during the period of convalescence. This diminution varied from a slight loss to complete absence of protective substances. In several instances there was a slight return of protective power during late convalescence. It was thought at one time that the disappearance of antibodies might have some connection with the continuance of slight fever after the critical fall of temperature, but the same phenomenon has been observed in patients that remained afebrile after the: crisis.
CONCLUSIONS.
These experiments demonstrate that protective substances are usually present in the blood of patients recovering from lobar pneumonia. As a rule, the appearance of protective bodies in the blood, when demonstrable, coincides rather sharply with the period of critical fall in temperature and the disappearance of symptoms. These substances are not present in the blood in .any measurable degree before the crisis, but afterward they may reach a considerable concentration. In certain instances, protective substances either become evident some time after the occurrence of the crisis, or cannot be demonstrated at any period of the disease. Experiments in which it is possible to test serum against an homologous strain of pneumococcus yield in the majority of cases evidence of the presence of protective bodies; whereas in those in which stock cultures are used, the serum, as a rule, shows no protection. The development of specific protective substances in the serum of patients with lobar pneumonia suggests that these bodies may play a part in the mechanism of recovery.
